MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in MoonLake Immunotherapeutics as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- −3 vs. Q2 2021
- Shares held
- 11.2M
- +24.5K (+0.2%) vs. Q2 2021
- Total value
- $111.1M
- −$4.70M (−4.1%) vs. Q2 2021
- New holders
- 1
- 8 more added
- Sold out
- 4
- 6 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $1.43B |
| Q1 2026 | 147 | $1.17B |
| Q4 2025 | 130 | $742.9M |
| Q3 2025 | 134 | $269.7M |
| Q2 2025 | 130 | $2.77B |
| Q1 2025 | 136 | $2.34B |
| Q4 2024 | 116 | $3.43B |
| Q3 2024 | 109 | $3.14B |
| Q2 2024 | 111 | $2.67B |
| Q1 2024 | 114 | $2.99B |
| Q4 2023 | 125 | $3.53B |
| Q3 2023 | 118 | $3.21B |
| Q2 2023 | 83 | $2.86B |
| Q1 2023 | 43 | $843.2M |
| Q4 2022 | 33 | $396.4M |
| Q3 2022 | 24 | $291.4M |
| Q2 2022 | 23 | $190.1M |
| Q1 2022 | 27 | $123.4M |
| Q4 2021 | 45 | $112.8M |
| Q3 2021 | 43 | $111.1M |
| Q2 2021 | 46 | $115.8M |
| Q1 2021 | 42 | $108.9M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 1,011,589 | $10.1M | 0.02% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 756,303 | $7.46M | 0.00% | 00.0% | Unchanged |
| RTW Investments, LP | 750,000 | $7.39M | 0.11% | 00.0% | Unchanged |
| BlackRock Inc. | 747,863 | $7.37M | 0.00% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 700,000 | $6.96M | 0.10% | 00.0% | Unchanged |
| Citadel Advisors LLC | 685,937 | $6.77M | 0.01% | −5,794−0.8% | Reduced |
| Staley Capital Advisers Inc | 580,000 | $5.71M | 0.31% | +80,000+16.0% | Added |
| Ghost Tree Capital, LLC | 500,000 | $4.94M | 1.63% | 00.0% | Unchanged |
| Wellington Management Group LLP | 483,887 | $4.78M | 0.00% | −32,409−6.3% | Reduced |
| Cormorant Asset Management, LP | 430,000 | $4.28M | 0.17% | 00.0% | Unchanged |
| Boxer Capital, LLC | 400,000 | $3.98M | 0.14% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 400,000 | $3.95M | 0.97% | 00.0% | Unchanged |
| Avidity Partners Management LP | 400,000 | $3.94M | 0.10% | 00.0% | Unchanged |
| Finepoint Capital LP | 382,400 | $3.77M | 0.64% | +32,400+9.3% | Added |
| Alyeska Investment Group, L.P. | 320,000 | $3.18M | 0.04% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 250,000 | $2.49M | 0.15% | 00.0% | Unchanged |
| Altium Capital Management LP | 250,000 | $2.49M | 0.66% | 00.0% | Unchanged |
| Foresite Capital Management V, LLC | 250,000 | $2.49M | 0.77% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 250,000 | $2.47M | 0.08% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 223,906 | $2.22M | 1.29% | −10,114−4.3% | Reduced |
| EcoR1 Capital, LLC | 200,000 | $1.99M | 0.07% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 154,500 | $1.54M | 0.03% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 150,000 | $1.49M | 0.08% | 00.0% | Unchanged |
| BlueCrest Capital Management Ltd | 150,000 | $1.49M | 0.07% | 00.0% | Unchanged |
| Consonance Capital Management LP | 150,000 | $1.49M | 0.82% | 00.0% | Unchanged |
| Picton Mahoney Asset Management | 70,000 | $692.0K | 0.03% | 00.0% | Unchanged |
| Cowen and Company, LLC | 62,475 | $622.0K | 0.03% | +62,475 | New |
| Magnetar Financial LLC | 61,557 | $608.0K | 0.01% | +353+0.6% | Added |
| Glazer Capital, LLC | 58,541 | $577.0K | 0.01% | +692+1.2% | Added |
| Millennium Management LLC | 55,735 | $555.0K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 50,000 | $498.0K | 0.03% | 00.0% | Unchanged |
| TD Asset Management Inc | 44,766 | $442.0K | 0.00% | 00.0% | Unchanged |
| Meridian Wealth Management, LLC | 42,094 | $415.0K | 0.05% | +15,094+55.9% | Added |
| D. E. Shaw & Co., Inc. | 40,053 | $395.0K | 0.00% | +17,040+74.0% | Added |
| Exos Asset Management LLC | 25,100 | $250.0K | 0.13% | 00.0% | Unchanged |
| Radcliffe Capital Management, L.P. | 25,131 | $248.0K | 0.01% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 25,000 | $247.0K | 0.00% | 00.0% | Unchanged |
| Nomura Holdings Inc | 22,733 | $226.0K | 0.00% | −2,216−8.9% | Reduced |
| Caxton Corp | 16,009 | $158.0K | 0.13% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 15,168 | $150.0K | 0.00% | −33,095−68.6% | Reduced |
| HRT Financial LP | 14,251 | $140.0K | 0.00% | −70.0% | Reduced |
| Morgan Stanley | 13,449 | $132.0K | 0.00% | +7,549+127.9% | Added |
| Tower Research Capital LLC (TRC) | 117 | $1.00K | 0.00% | +100+588.2% | Added |
| Logos Global Management LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −7,212−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −374−100.0% | Sold out |